Regenera Pharma Ltd. is an clinical-stage pharmaceutical company focused on the development of innovative regenerative therapy which enables the body to repair by regenerating damaged tissues.

A Revolutionary Breakthrough
Reversing Neurological Damage

In pre-clinical studies, our leading drug candidate, RPh201, has been shown to:

• Reverse neurological damage, inducing neurogenesis and synaptogenesis
• Improve cognitive functions
• Recover both short- and long-term memories
• Restore motor functions
• Expedite wound healing

For tens of millions of people worldwide suffering from neurodegenerative diseases and chronic non-healing wounds, RPh201 is their long-awaited breakthrough, that will revolutionize the treatment paradigms.